Tantichariyangkul P, Dilokthornsakul P, Khotcharrat R, Sawatdiwithayayong J, Bhoopat T, Upakdee N
BMC Ophthalmol. 2024; 24(1):539.
PMID: 39695504
PMC: 11658330.
DOI: 10.1186/s12886-024-03808-9.
Yoshioka H, Ueta M, Fukuoka H, Yokoi N, Mizushima K, Naito Y
Invest Ophthalmol Vis Sci. 2024; 65(6):37.
PMID: 38935029
PMC: 11216254.
DOI: 10.1167/iovs.65.6.37.
Wiebe-Ben Zakour K, Kaya S, Grumm L, Matros J, Hacker M, Geerling G
Invest Ophthalmol Vis Sci. 2024; 65(5):24.
PMID: 38748430
PMC: 11098053.
DOI: 10.1167/iovs.65.5.24.
Peng R, Chi M, Xiao G, Qu H, Shen Z, Zhao Y
BMC Ophthalmol. 2024; 24(1):205.
PMID: 38711013
PMC: 11071215.
DOI: 10.1186/s12886-024-03461-2.
Aziza Y, Imai K, Itoi M, Yoshioka H, Komai S, Kitazawa K
Br J Ophthalmol. 2023; 108(8):1177-1183.
PMID: 37918892
PMC: 11287622.
DOI: 10.1136/bjo-2023-323617.
Case report: Concomitant use of nightly vitamin A ointment with daily PROSE wear for ocular surface disease associated with chronic Stevens-Johnson syndrome.
Shlager G, Nakhla M, Pritchett D, Brocks D
Am J Ophthalmol Case Rep. 2023; 32:101943.
PMID: 37915728
PMC: 10616137.
DOI: 10.1016/j.ajoc.2023.101943.
Severe ocular complications of SJS/TEN and associations among pre-onset, acute, and chronic factors: a report from the international ophthalmology collaborative group.
Ueta M, Inoue C, Nakata M, Sotozono C, Kim M, Wakamatsu T
Front Med (Lausanne). 2023; 10:1189140.
PMID: 37425307
PMC: 10325566.
DOI: 10.3389/fmed.2023.1189140.
Ocular surface involvement and histopathologic changes in the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional study.
Liu Y, Feng J, Ren Y, Shi W, Kang H, Peng Y
BMC Ophthalmol. 2023; 23(1):297.
PMID: 37400766
PMC: 10316600.
DOI: 10.1186/s12886-023-03052-7.
Ophthalmic Aspects of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Narrative Review.
Toth G, Lukacs A, Schirra F, Sandor G, Killik P, Maneschg O
Ophthalmol Ther. 2023; 12(4):1795-1811.
PMID: 37140876
PMC: 10157599.
DOI: 10.1007/s40123-023-00725-w.
Chronic ocular sequelae in Stevens-Johnson syndrome: a genetic association study.
Sangwan S, Sharma N, Agarwal T, Khanna N, Pandey R, Sharma A
Mol Vis. 2023; 28:526-535.
PMID: 37089698
PMC: 10115362.
Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens-Johnson Syndrome Cases.
Yoshikawa Y, Ueta M, Kinoshita S, Kida T, Sotozono C
Eye Contact Lens. 2023; 49(6):247-253.
PMID: 37053071
PMC: 10513020.
DOI: 10.1097/ICL.0000000000000989.
Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management.
Donthineni P, Doctor M, Shanbhag S, Kate A, Galor A, Djalilian A
Indian J Ophthalmol. 2023; 71(4):1332-1347.
PMID: 37026265
PMC: 10276701.
DOI: 10.4103/IJO.IJO_2808_22.
Contact lenses in dry eye disease and associated ocular surface disorders.
Chaudhary S, Ghimire D, Basu S, Agrawal V, Jacobs D, Shanbhag S
Indian J Ophthalmol. 2023; 71(4):1142-1153.
PMID: 37026246
PMC: 10276711.
DOI: 10.4103/IJO.IJO_2778_22.
Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management.
Thorel D, Ingen-Housz-Oro S, Benaim D, Daien V, Gabison E, Saunier V
Orphanet J Rare Dis. 2023; 18(1):51.
PMID: 36906580
PMC: 10007779.
DOI: 10.1186/s13023-023-02616-6.
Diagnostic Algorithm for Surgical Management of Limbal Stem Cell Deficiency.
Malyugin B, Kalinnikova S, Isabekov R, Ostrovskiy D, Knyazer B, Gerasimov M
Diagnostics (Basel). 2023; 13(2).
PMID: 36673009
PMC: 9858342.
DOI: 10.3390/diagnostics13020199.
Treatment of Severe Dry Eye in Stevens-Johnson Syndrome with Umbilical Cord Serum Eye Drops.
Susiyanti M, Kurnia D, Fasha I, Irawati Y, Rachmadi L, Liem I
Clin Ophthalmol. 2022; 16:4089-4095.
PMID: 36532819
PMC: 9749407.
DOI: 10.2147/OPTH.S385078.
Lack of Retinoblastoma Protein Shifts Tumor Metabolism from Glycolysis to OXPHOS and Allows the Use of Alternate Fuels.
Babu V, Dudeja G, Sa D, Bisht A, Shetty R, Heymans S
Cells. 2022; 11(20).
PMID: 36291051
PMC: 9600484.
DOI: 10.3390/cells11203182.
Ocular manifestations in acute stage Stevens-Johnson syndrome/toxic epidermal necrolysis - A retrospective study in a tertiary hospital in South India.
Pradeep T, Shetti S
Taiwan J Ophthalmol. 2022; 12(2):184-190.
PMID: 35813799
PMC: 9262012.
DOI: 10.4103/tjo.tjo_13_21.
Regression of corneal opacity and neovascularization in Stevens-Johnson syndrome and Toxic Epidermal Necrolysis with the use of prosthetic replacement of the ocular surface ecosystem (PROSE) treatment.
Liao J, Asghari B, Carrasquillo K
Am J Ophthalmol Case Rep. 2022; 26:101520.
PMID: 35464679
PMC: 9027328.
DOI: 10.1016/j.ajoc.2022.101520.
Matrix metalloproteinase 9 is associated with conjunctival microbiota culture positivity in Korean patients with chronic Stevens-Johnson syndrome.
Moon J, Lee Y, Yoon C, Kim M
BMC Ophthalmol. 2022; 22(1):179.
PMID: 35440028
PMC: 9019957.
DOI: 10.1186/s12886-022-02406-x.